Literature DB >> 24560755

Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin.

Shaojun Lin1, Jianji Pan2, Lu Han3, Qiaojuan Guo1, Cairong Hu3, Jingfeng Zong1, Xiuchun Zhang3, Jiade Jay Lu4.   

Abstract

BACKGROUND AND
PURPOSE: To establish the minimally required margins in different directions measured from GTV in the definitive treatment of nasopharyngeal carcinoma (NPC) using IMRT based on the 5-year results. METHODS AND MATERIALS: Between November 2003 and May 2007, 414 patients with non-metastatic NPC were treated with IMRT according to our institutional protocol. Treatment outcomes at 5 years were analyzed. Distances from GTV-T to CTV2 (i.e., CTV 59.4 Gy) in 6 directions (anterior, posterior, superior, inferior, and bilateral) were measured and analyzed.
RESULTS: The 5-year estimated overall survival (OS), disease free survival (DFS), local control (LC) were 80%, 77% and 95%, respectively. For the margins measured from GTV-T to CTV2, margins used with T4 disease were significantly and uniformly smaller than the whole group in all the 6 directions (P=0.000, 0.000, 0.000, 0.000 and 0.046, respectively). However, no increase of local recurrence was associated to this limited margins used.
CONCLUSIONS: Our 5-years' experience showed a very high LC rate. The strategy we used for CTV delineation was safe and reliable. Determined CTV through GTV expansion to a minimally required margin, using GTV+margin (used in our T4 patients)+the whole nasopharyngeal mucosa, especially for the patients with early T disease, might be feasible. Crown
Copyright © 2014. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chemoradiation; IMRT; Intensity-modulated radiation therapy; Nasopharyngeal carcinoma; Optimal margins; Radiotherapy

Mesh:

Year:  2014        PMID: 24560755     DOI: 10.1016/j.radonc.2014.01.011

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  51 in total

1.  Radical resection for solitary thoracic spinous-process metastasis: a case report and technical note.

Authors:  Chikako Ishii; Akira Iwata; Katsuhisa Yamada; Tsutomu Endo; Takeru Tsujimoto; Hideki Sudo; Ai Shimizu; Norimasa Iwasaki; Masahiko Takahata
Journal:  Spinal Cord Ser Cases       Date:  2022-01-17

2.  Comparison of intensity-modulated radiation therapy alone vs. intensity-modulated radiation therapy combined with chemotherapy in elderly nasopharyngeal carcinoma patients (aged >65 years).

Authors:  Jing-Lin Mi; Yi-Liang Meng; Hong-Liang Wu; Yi-Lin Cao; Bin Zhang; Yu-Fei Pan; Yuan-Yuan Zhou; Jin-Fang Fan; Shu-Fang Liao; Xiao-Li Qin; Da-Cheng Yao; Wei Jiang
Journal:  Strahlenther Onkol       Date:  2019-11-20       Impact factor: 3.621

3.  Systemic immune-inflammation index as a prognostic marker in patients with newly diagnosed metastatic nasopharyngeal carcinoma: a propensity score-matched study.

Authors:  Cheng Lin; Sheng Lin; Qiao-Juan Guo; Jing-Feng Zong; Tian-Zhu Lu; Na Lin; Shao-Jun Lin; Jian-Ji Pan
Journal:  Transl Cancer Res       Date:  2019-09       Impact factor: 1.241

4.  Is Gemcitabine and Cisplatin Induction Chemotherapy Superior in Locoregionally Advanced Nasopharyngeal Carcinoma?

Authors:  Wei Zheng; Sufang Qiu; Lingling Huang; Jianji Pan
Journal:  Pak J Med Sci       Date:  2015 Jul-Aug       Impact factor: 1.088

5.  Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy?

Authors:  Yong Chen; Xue-Feng Hu; Yan Wang; Hai-Yang Chen; Lin Yang; Li-Zhi Liu; Chun-Yan Cui; Dong-Sheng Liu; Shao-Bo Liang
Journal:  BMC Cancer       Date:  2015-04-18       Impact factor: 4.430

6.  Concurrent chemotherapy for T4 classification nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.

Authors:  Cai-neng Cao; Jing-wei Luo; Li Gao; Jun-lin Yi; Xiao-dong Huang; Kai Wang; Shi-ping Zhang; Yuan Qu; Su-yan Li; Jian-ping Xiao; Zhong Zhang; Guo-zhen Xu
Journal:  PLoS One       Date:  2015-03-06       Impact factor: 3.240

7.  Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.

Authors:  Lu Zhang; Lin-Quan Tang; Qiu-Yan Chen; Huai Liu; Shan-Shan Guo; Li-Ting Liu; Ling Guo; Hao-Yuan Mo; Chong Zhao; Xiang Guo; Ka-Jia Cao; Chao-Nan Qian; Mu-Sheng Zeng; Jian-Yong Shao; Ying Sun; Jun Ma; Ming-Huang Hong; Hai-Qiang Mai
Journal:  Oncotarget       Date:  2016-02-02

8.  Maximal lymph nodal diameter on N stage of nasopharyngeal carcinoma.

Authors:  Shi-Ting Huang; Song Qu; Ling Li; Kai-Hua Chen; Xiao-Dong Zhu; Xin-Bin Pan
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817

9.  The prognostic significance of race in nasopharyngeal carcinoma by histological subtype.

Authors:  Katelyn O Stepan; Angela L Mazul; S Andrew Skillington; Randal C Paniello; Jason T Rich; Jose P Zevallos; Ryan S Jackson; Patrik Pipkorn; Sean Massa; Sidharth V Puram
Journal:  Head Neck       Date:  2021-02-23       Impact factor: 3.821

10.  Puquitinib mesylate (XC-302) induces autophagy via inhibiting the PI3K/AKT/mTOR signaling pathway in nasopharyngeal cancer cells.

Authors:  Ke-Feng Wang; Hang Yang; Wen-Qi Jiang; Su Li; Yu-Chen Cai
Journal:  Int J Mol Med       Date:  2015-10-16       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.